Plasmodium vevax and P. falciparum: Biological interactions and the possibility of cross-species immunity.
about
Estimating the global clinical burden of Plasmodium falciparum malaria in 2007A long neglected world malaria map: Plasmodium vivax endemicity in 2010The international limits and population at risk of Plasmodium vivax transmission in 2009The effect of alpha+-thalassaemia on the incidence of malaria and other diseases in children living on the coast of KenyaArtemisinin combination therapy for vivax malariaPlasmodium species mixed infections in two areas of Manhiça district, MozambiqueThe anaemia of Plasmodium vivax malariaMajor burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance studyBeyond mice and men: environmental change, immunity and infections in wild ungulatesThe spatial and temporal patterns of falciparum and vivax malaria in Perú: 1994-2006Vivax malaria: neglected and not benignPlasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea.Severe vivax malaria: newly recognised or rediscoveredEffect of transmission setting and mixed species infections on clinical measures of malaria in Malawi.ama1 genes of sympatric Plasmodium vivax and P. falciparum from Venezuela differ significantly in genetic diversity and recombination frequency.Heritability of P. falciparum and P. vivax malaria in a Karen population in Thailand.Multispecies Plasmodium infections of humansImmune responses of NIH mice infected with avirulent and virulent strains of Plasmodium chabaudi adami single and mixed infections.Sub-microscopic malaria cases and mixed malaria infection in a remote area of high malaria endemicity in Rattanakiri province, Cambodia: implication for malaria elimination.A rare case of quadruple malaria infection from the highly malaria-endemic area of Bastar, Chhattisgarh, India.Malaria on isolated Melanesian islands prior to the initiation of malaria elimination activities.The potential impact of native Australian trypanosome infections on the health of koalas (Phascolarctos cinereus).Severe anemia in Papua New Guinean children from a malaria-endemic area: a case-control etiologic study.Comparative population structure of Plasmodium malariae and Plasmodium falciparum under different transmission settings in Malawi.Molecular detection of malaria in South punjab with higher proportion of mixed infections.Defining the relationship between Plasmodium falciparum parasite rate and clinical disease: statistical models for disease burden estimation.The molecular epidemiology of malaria.Comparing methods of estimating the global morbidity burden from Plasmodium falciparum malariaFactors contributing to anemia after uncomplicated falciparum malaria.Quantifying genetic and nongenetic contributions to malarial infection in a Sri Lankan population.Antigenic diversity and immune evasion by malaria parasites.Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia.Plasmodium vivax infection: a major determinant of severe anaemia in infancy.Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?Longitudinal study of Plasmodium falciparum and Plasmodium vivax in a Karen population in ThailandBlood-stage dynamics and clinical implications of mixed Plasmodium vivax-Plasmodium falciparum infectionsWhat Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates?Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivax.Comparison of the diagnostic performance of microscopic examination with nested polymerase chain reaction for optimum malaria diagnosis in Upper MyanmarImmune response to Plasmodium vivax has a potential to reduce malaria severity.
P2860
Q17485684-C6C70509-2C61-47FD-937D-146D0AD8B2D6Q21144495-93F888CD-3B09-4F0E-A044-13890577879DQ21144525-E75DC09D-DDBB-4BF3-B254-0A8542C191B7Q21144709-3CE8C7E2-C72E-4F37-90C5-56CCCBD1167BQ24622539-21907947-0FAA-4D21-BD32-0A2DB5616B19Q24816067-4496AE32-DB87-4CB9-918F-2B4CBB806BE5Q27026970-E1D3E1BE-CEE9-4C37-9377-C2C043E1B102Q28537653-234D4D6E-A7E6-4A9A-B236-C125C10552EBQ28648197-2339F7E6-17DF-4A95-AD72-DF139525CA22Q28752188-6FB2C7E1-43E0-4482-9808-D602CB42C865Q29619167-6FD70127-64E4-4F26-AC5F-22DF255C00E8Q33344896-69420E86-27BC-4AE9-BBE8-0DC50A804FE9Q33344909-1E14A13B-AA86-448C-B2F3-1EF5D89FFECAQ33354167-F73F9A6D-CCCA-4D3E-B997-F0B334C562A4Q33375053-256623E6-2331-4076-9D5C-60EB31C76EFDQ33390376-8BA6CA83-A482-4B4E-B010-B1E97E21E540Q33596156-40759AD5-C01D-4CEF-A494-CB9F97F0CB2CQ33746686-6D375D96-CF4D-425D-8315-09BB4DEC097EQ33846640-4B320742-3666-45EE-906F-CBCE345897CFQ33879484-5F93B414-9253-48D9-BBFC-CABC8E9A8B8DQ34063659-2BE6F6A3-A318-46CE-9086-7C516B5DF37CQ34180679-8298DA06-9251-4A63-87B7-FA02C3013CB8Q34526286-F9E474E4-89D5-479D-A561-ECB4E6F3314BQ34633251-0D50A4E5-ADCE-471A-BE0C-2BCA848C6A11Q34905809-C9CADAAE-2618-46B5-B58D-43BE628D2B58Q34995744-B8787339-68AE-4BC0-A86E-4F882EDF96F8Q35013405-783363E3-B33C-4623-9A72-BF0CC9CE1C31Q35087671-C3702ABB-48CB-44B7-805E-7384AEFD01A7Q35112361-8148117C-640F-4986-A579-B815F8F8AED5Q35821504-CC653BE5-8A2F-4D42-8835-B2B0970FDFDEQ35946430-4F4AB42C-EE52-4F23-A590-0721F60A81D6Q35998522-CEA574A4-C527-4DA2-AA04-44D19A6801F5Q36053392-1AE52AF3-BF14-4BC6-902C-CB4352A28455Q36483682-2C531399-04EE-40CE-BF77-AAD9636D6C65Q36744597-5B24A0C9-F63F-445D-A98C-53F242748CADQ36791087-42C28794-44B5-4890-B5E9-7DEB63C1B9A8Q37638131-82E13728-CC29-46A6-A4FD-CAFCB343F7F7Q37682153-E493BF0B-7160-41CF-88DD-CE837C79D68CQ37708309-537E57AE-FC33-46A5-99EA-09971909C4B5Q38946873-6182C044-D763-4A56-A2ED-0475E36DBBAB
P2860
Plasmodium vevax and P. falciparum: Biological interactions and the possibility of cross-species immunity.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Plasmodium vevax and P. falcip ...... ity of cross-species immunity.
@en
Plasmodium vevax and P. falcip ...... ity of cross-species immunity.
@nl
type
label
Plasmodium vevax and P. falcip ...... ity of cross-species immunity.
@en
Plasmodium vevax and P. falcip ...... ity of cross-species immunity.
@nl
prefLabel
Plasmodium vevax and P. falcip ...... ity of cross-species immunity.
@en
Plasmodium vevax and P. falcip ...... ity of cross-species immunity.
@nl
P1433
P1476
Plasmodium vevax and P. falcip ...... ity of cross-species immunity.
@en
P2093
Williams TN
P304
P356
10.1016/S0169-4758(97)01061-2
P577
1997-06-01T00:00:00Z